Insights On Pharmaceutical Packaging
-
FAQs On The Revised EU GMP Annex 1: Volume 2
3/5/2025
Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.
-
Advancing Health Through Decades Of Packaging Innovation
2/27/2026
A legacy of packaging expertise evolved into a mission centered on helping life‑changing medicines reach people. See how purpose, curiosity, and partnership drive continued growth.
-
Sachet Packaging Solutions
3/4/2025
Discover versatile, high-quality sachets for manufacturers and consumers with an ideal fill weight of 2 grams and above that is suitable for food or liquid formulas.
-
Meeting Annex 1: A Proactive Approach To Regulatory Compliance
3/4/2025
It was imperative for a large European CMO producing multiple biologics to select the right product quality and value for each customer to comply with the August 2023 EU GMP Annex 1 revision.
-
Ensuring Tablet Logo Legibility: A Critical Step In Preventing Medication Errors
11/11/2024
Tablet debossing aids medication identification and must meet FDA standards. Font, scale, color, shadow, and stroke details are key for optimal legibility and safety.
-
Optimal Syringe Carton Design To Meet Drug Manufacturers' Needs
8/1/2024
Learn about the advantages of an optimal packaging design and the resulting benefits of its implementation to the overall process.
-
Precision And Reliability For Medical Device Packaging
12/29/2025
Learn how to detect critical defects, reduce risk, and ensure compliance through flexible service options and data-driven testing that eliminates subjectivity in medical device packaging quality assurance.
-
Reducing Risks By Outsourcing OSD Manufacturing And Packaging
10/23/2024
Watch to discover the key benefits of outsourcing your OSD production and explore real-world examples and best practices to help you streamline your processes and enhance your operational agility.
-
Providing Packing And Blinding Solutions For An Innovative Drug Start-Up
9/13/2024
Discover how a CDMO with integrated services enabled a botanical drug start-up to commence its Phase 1 clinical trial, paving the way for further advancement of its innovative botanical drug.
-
Improve Speed To Market By Mitigating Vial And Stopper Incompatibility
10/1/2024
These studies indicate that with a properly assembled vial containment system, good CCI performance can be achieved with stoppers of a given elastomer, independent of configuration/size, or vial style.